Blue Sail Medical Co.,Ltd. (SHE:002382)
China · Delayed Price · Currency is CNY 7.08
+0.16 (2.31%)
May 8, 2026, 3:04 PM CST
Blue Sail Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -880.74 | -798.41 | -445.61 | -568.36 | -372.32 | 1,156 |
Depreciation & Amortization | 572.52 | 572.52 | 526 | 524.51 | 489.01 | 332.16 |
Other Amortization | 16.03 | 16.03 | 32.61 | 50.88 | 51.44 | 34.54 |
Loss (Gain) From Sale of Assets | 1.65 | 1.65 | 0.84 | 1.92 | -0.07 | 1.98 |
Asset Writedown & Restructuring Costs | 248.4 | 248.4 | 6.29 | 21.47 | 6.94 | 2,069 |
Loss (Gain) From Sale of Investments | -16.8 | -16.8 | 11.1 | -83.56 | -252.45 | -1,123 |
Provision & Write-off of Bad Debts | - | - | 22.74 | 18.69 | 1.91 | 20.1 |
Other Operating Activities | 195.86 | 254.55 | 235.02 | 233.45 | 161.99 | 188.73 |
Change in Accounts Receivable | 194.15 | 194.15 | -311.05 | -247.61 | 413.41 | 182.7 |
Change in Inventory | 10.22 | 10.22 | -207.17 | -146.32 | 176.54 | -426.52 |
Change in Accounts Payable | 49.14 | 49.14 | 262.3 | 199.73 | -165.95 | -220.63 |
Change in Other Net Operating Assets | 1.37 | 1.37 | 9.2 | 20.45 | 43.24 | 19.62 |
Operating Cash Flow | 316.7 | 457.72 | 135.85 | -72.89 | 494.47 | 2,246 |
Operating Cash Flow Growth | -19.54% | 236.93% | - | - | -77.98% | -38.84% |
Capital Expenditures | -415.12 | -553.01 | -774.28 | -774.14 | -896.86 | -2,582 |
Sale of Property, Plant & Equipment | 4.69 | 2.6 | 1.67 | 2.56 | 10.98 | 6.37 |
Cash Acquisitions | -228.76 | -228.76 | - | - | -53.25 | - |
Investment in Securities | 73.3 | -507.39 | 50.76 | -130.08 | 1,015 | 33.06 |
Other Investing Activities | 25.2 | 22.18 | 6.42 | 30.91 | 38.74 | 49.45 |
Investing Cash Flow | -540.7 | -1,264 | -715.44 | -870.75 | 114.82 | -2,493 |
Long-Term Debt Issued | - | 878 | 1,644 | 1,040 | 142.76 | 1,477 |
Total Debt Issued | 493.3 | 878 | 1,644 | 1,040 | 142.76 | 1,477 |
Long-Term Debt Repaid | - | -882.84 | -1,824 | -393.24 | -793.42 | -1,984 |
Total Debt Repaid | -1,252 | -882.84 | -1,824 | -393.24 | -793.42 | -1,984 |
Net Debt Issued (Repaid) | -759.14 | -4.84 | -180.18 | 647.08 | -650.66 | -506.26 |
Issuance of Common Stock | - | - | 0.02 | - | - | - |
Repurchase of Common Stock | - | - | -30 | - | - | - |
Common Dividends Paid | -160.71 | -168.38 | -177.44 | -513.78 | -61.02 | -477.2 |
Other Financing Activities | 494.7 | 711.54 | 1,710 | - | -0.01 | 6.45 |
Financing Cash Flow | -425.16 | 538.32 | 1,323 | 133.31 | -711.69 | -977.02 |
Foreign Exchange Rate Adjustments | -32.77 | -2.6 | -7.22 | 20.56 | 59.63 | 48.07 |
Net Cash Flow | -681.93 | -270.93 | 735.95 | -789.77 | -42.77 | -1,176 |
Free Cash Flow | -98.42 | -95.29 | -638.43 | -847.03 | -402.39 | -336.22 |
Free Cash Flow Margin | -1.69% | -1.66% | -10.21% | -17.19% | -8.21% | -4.15% |
Free Cash Flow Per Share | - | -0.10 | -0.63 | -0.83 | -0.40 | -0.32 |
Cash Interest Paid | - | - | 3.75 | 3.93 | - | - |
Cash Income Tax Paid | - | -162.63 | -314.21 | -270.3 | -540.33 | -69.07 |
Levered Free Cash Flow | 325.55 | -123.02 | -1,106 | -994.93 | -866.98 | -48.7 |
Unlevered Free Cash Flow | 325.55 | -123.02 | -931.72 | -882.14 | -786.05 | 34.62 |
Change in Working Capital | 179.79 | 179.79 | -253.16 | -271.9 | 408.01 | -434.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.